1. Home
  2. ALGT vs NTLA Comparison

ALGT vs NTLA Comparison

Compare ALGT & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allegiant Travel Company

ALGT

Allegiant Travel Company

HOLD

Current Price

$82.32

Market Cap

1.4B

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$13.12

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALGT
NTLA
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
ALGT
NTLA
Price
$82.32
$13.12
Analyst Decision
Hold
Buy
Analyst Count
10
20
Target Price
$97.00
$20.45
AVG Volume (30 Days)
443.7K
3.7M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
81.62
27.43
EPS
N/A
N/A
Revenue
$2,606,579,000.00
$67,671,000.00
Revenue This Year
$5.81
N/A
Revenue Next Year
$8.05
$62.75
P/E Ratio
N/A
N/A
Revenue Growth
3.74
16.92
52 Week Low
$39.82
$5.90
52 Week High
$118.00
$28.24

Technical Indicators

Market Signals
Indicator
ALGT
NTLA
Relative Strength Index (RSI) 44.05 49.96
Support Level $54.65 $12.55
Resistance Level $94.50 $14.61
Average True Range (ATR) 4.97 0.69
MACD -0.42 -0.10
Stochastic Oscillator 32.74 35.74

Price Performance

Historical Comparison
ALGT
NTLA

About ALGT Allegiant Travel Company

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in underserved cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates the maximum revenue, and Sunseeker Resort.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: